Transdiagnostic quantitative assessment of dementias using in vivo MRI and data-driven disease progression modelling: a case study in Alzheimer's disease and dementia with Lewy bodies
This study demonstrates that a data-driven transdiagnostic approach using single-visit MRI can identify three distinct brain atrophy subtypes across Alzheimer's disease and dementia with Lewy bodies, offering a promising tool for in vivo biological staging and subtyping despite imperfect alignment with clinical diagnoses.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Imagine your brain as a massive, bustling city. For years, doctors have tried to diagnose dementia by looking at the city's "traffic jams" (symptoms like memory loss or confusion). But here's the tricky part: two very different diseases, Alzheimer's and Dementia with Lewy Bodies, can cause traffic jams that look almost identical from the street. It's like trying to tell the difference between a fire and a flood just by seeing that the streets are blocked.
Usually, to know for sure which disaster is happening, you'd need to send a special team inside to check the pipes (biomarkers) or wait until the building is empty to inspect the damage (autopsy). But those methods are expensive, invasive, or not yet ready for regular use.
So, a team of researchers asked a new question: Instead of just looking at how much the city is damaged, what if we look at where the damage starts and how it spreads?
The Big Discovery: Three Different Blueprints
The researchers used a super-smart computer program (called SuStaIn) to scan MRI pictures of brains from over 3,000 people across six different groups. They didn't just look for "sick" brains; they looked for patterns in how the brain's "buildings" (regions) shrink over time.
They found that the city doesn't just crumble randomly. Instead, the damage follows one of three distinct blueprints:
- The "Limbic" Blueprint: The damage starts deep in the city's emotional and memory center (the limbic system) and slowly spreads outward. This pattern is mostly seen in people with Alzheimer's.
- The "Cortical" Blueprint: The damage starts on the city's outer edges (the cortex) and works its way inward. This pattern is mostly seen in people with Dementia with Lewy Bodies.
- The "Cortico-Limbic" Blueprint: This is the messy middle ground. The damage happens in both the center and the edges at the same time. This suggests a mix of both diseases happening together.
Think of it like a house fire. One blueprint shows the fire starting in the basement (Limbic/Alzheimer's). Another shows the fire starting in the attic (Cortical/Lewy Bodies). The third shows the fire raging in both the basement and attic simultaneously (Mixed).
What the Data Actually Says (and What It Doesn't)
The researchers checked these blueprints against real-world clues to see if they made sense.
- The "Memory" Clue: People with the "Cortical" blueprint (Lewy Bodies) tended to have better memory scores early on compared to the others. It's like the attic fire hasn't burned down the library yet, even though the roof is smoking.
- The "Genetic" Clue: People with the "Limbic" and "Cortico-Limbic" blueprints were much more likely to carry a specific genetic risk factor (APOE ε4) known to be linked to Alzheimer's. The "Cortical" group had much less of this genetic risk.
- The "Chemical" Clue: When they looked at spinal fluid (the city's plumbing), the "Limbic" and "Cortico-Limbic" groups had higher levels of Alzheimer's-related proteins (amyloid and tau). The "Cortical" group had lower levels.
- The "Autopsy" Clue: In the small group of people who had been examined after death, those with the "Limbic" blueprint almost always had confirmed Alzheimer's disease. Those with the "Cortical" blueprint were more likely to have Lewy bodies.
Crucially, the paper rules out a few things:
- It is not true that these diseases are completely random or that every patient fits into just one big "dementia" bucket. The data shows clear, separate patterns.
- It is not true that the "Cortical" blueprint is just a mild version of Alzheimer's. It has a different starting point, a different genetic profile, and a different chemical signature.
- The paper does not claim that alpha-synuclein (the protein linked to Lewy bodies) was found in higher amounts in the "Cortical" group. In fact, the study found no statistical difference in alpha-synuclein levels across the three groups, even though they expected to see a difference. This suggests that while the shape of the damage is different, the chemical evidence for Lewy bodies in this specific dataset was too patchy to draw a firm line.
How Sure Are We?
The authors are suggesting that this "three-blueprint" system is a powerful new way to look at dementia. They found strong statistical links between the brain patterns and the biological markers (like genetics and spinal fluid).
However, they are careful to say this is not a solved problem yet.
- The study relied on data from different groups, and some of the important chemical tests (like alpha-synuclein) were missing for many people.
- The "Cortical" group's link to Lewy bodies is based on the fact that they looked like Lewy Body patients and didn't look like Alzheimer's patients, but the direct chemical proof was incomplete.
- The authors explicitly state that their results are promising and suggest that a single MRI scan could eventually help doctors tell these diseases apart without needing expensive PET scans or spinal taps. But they admit that future studies with more complete data are needed to confirm this.
The Bottom Line
This research proposes that instead of asking "How sick is the patient?", we should ask "Which blueprint is the damage following?"
By using a single MRI scan, doctors might one day be able to say, "Ah, your brain is crumbling from the outside in (Cortical), which suggests Lewy Bodies," or "It's crumbling from the inside out (Limbic), which suggests Alzheimer's." It's a shift from guessing based on symptoms to reading the map of the damage itself. While the map is still being drawn and some details are fuzzy, the path forward looks much clearer than before.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.